David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Liberty Media Series C
FWONK
|
+$430M |
| 2 |
Alibaba
BABA
|
+$364M |
| 3 |
HP
HPQ
|
+$298M |
| 4 |
Pfizer
PFE
|
+$258M |
| 5 |
Booking.com
BKNG
|
+$244M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRX
FOREST LABORATORIES INC
FRX
|
+$602M |
| 2 |
Liberty Media Series A
FWONA
|
+$321M |
| 3 |
AbbVie
ABBV
|
+$312M |
| 4 |
GE Aerospace
GE
|
+$233M |
| 5 |
SNDK
SANDISK CORP
SNDK
|
+$183M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.23% |
| 2 | Consumer Discretionary | 8.61% |
| 3 | Energy | 8.3% |
| 4 | Healthcare | 6.98% |
| 5 | Communication Services | 6.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
PUT
Alaska Air
ALK
$4.64B
| $18.8M | 0.02% |
431,800
| – | – |
|
727
Edwards Lifesciences
EW
$52.2B
| $18.7M | 0.02% |
1,098,786
+836,244
| +319% | +$13.2M |
|
728
CALL
PepsiCo
PEP
$197B
| $18.7M | 0.02% |
200,700
-50,800
| -20% | -$4.64M |
|
729
PUT
Travelers Companies
TRV
$77.3B
| $18.6M | 0.02% |
197,800
| – | – |
|
|
ALXN
730
CALL
DELISTED
Alexion Pharmaceuticals
ALXN
| $18.6M | 0.02% |
111,900
-1,600
| -1% | -$263K |
|
731
CALL
CME Group
CME
$100B
| $18.5M | 0.02% |
230,800
+12,600
| +6% | +$950K |
|
732
CALL
Medtronic
MDT
$119B
| $18.4M | 0.02% |
296,600
-12,100
| -4% | -$769K |
|
|
SCTY
733
PUT
DELISTED
SolarCity Corporation
SCTY
| $18.4M | 0.02% |
308,100
-83,300
| -21% | -$5.73M |
|
734
Oil States International
OIS
$501M
| $18.3M | 0.02% |
296,297
+244,837
| +476% | +$15.4M |
|
735
APA Corp
APA
$15.1B
| $18.3M | 0.02% |
194,961
+181,569
| +1,356% | +$18M |
|
|
MDRX
736
DELISTED
Veradigm Inc. Common Stock
MDRX
| $18.2M | 0.02% |
1,359,389
+386,386
| +40% | +$5.86M |
|
737
Bloomin' Brands
BLMN
$980M
| $18.2M | 0.02% |
990,599
+63,160
| +7% | +$1.16M |
|
738
Radian Group
RDN
$4.86B
| $18.2M | 0.02% |
1,273,556
-420,973
| -25% | -$5.89M |
|
739
PUT
Thermo Fisher Scientific
TMO
$232B
| $18.1M | 0.02% |
149,100
| – | – |
|
|
WPG
740
DELISTED
Washington Prime Group Inc.
WPG
| $18.1M | 0.02% |
115,190
+39,726
| +53% | +$6.73M |
|
741
BioMarin Pharmaceuticals
BMRN
$12.6B
| $18.1M | 0.02% |
251,107
+135,138
| +117% | +$8.88M |
|
742
PUT
Eastman Chemical
EMN
$8.31B
| $18.1M | 0.02% |
223,400
| – | – |
|
743
Bankunited
BKU
$3.3B
| $18.1M | 0.02% |
592,643
-24,803
| -4% | -$790K |
|
|
SFR
744
DELISTED
Starwood Waypoint Homes
SFR
| $18M | 0.02% |
691,988
-207,583
| -23% | -$5.53M |
|
745
Sunstone Hotel Investors
SHO
$2.1B
| $18M | 0.02% |
1,301,552
+548,402
| +73% | +$7.96M |
|
|
AMTD
746
PUT
DELISTED
TD Ameritrade Holding Corp
AMTD
| $18M | 0.02% |
539,000
| – | – |
|
|
PLL
747
DELISTED
PALL CORP
PLL
| $17.8M | 0.02% |
213,146
+109,979
| +107% | +$9.01M |
|
748
3M
MMM
$92.3B
| $17.8M | 0.02% |
+150,505
| New | +$18.1M |
|
749
CALL
Clorox
CLX
$13B
| $17.7M | 0.02% |
184,500
| – | – |
|
|
ADVS
750
DELISTED
Advent Software Inc
ADVS
| $17.6M | 0.02% |
559,041
+548,433
| +5,170% | +$17.6M |
|
Similar funds
David Shaw's Q3 2014 Portfolio in Review
As of Q3 2014, David Shaw held 4,729 positions worth $77.2B, up 5.1% from $73.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw deployed $3.39B of net new capital in Q3 2014, opening 599 new positions and adding to 1,385 existing holdings. Its largest new stake was Liberty Media Series C: 16,804,239 shares worth $422M.
By sector, the portfolio is most concentrated in Technology at 9.2% of assets, up from 8.3% a quarter earlier, followed by Consumer Discretionary and Energy.
On the sell side, the largest reduction was Liberty Media Series A, an estimated $321M trimmed.
- David Shaw's largest Q3 2014 buy was Liberty Media Series C: 16,804,239 shares worth $422M.
- David Shaw added most to HP in Q3 2014, an estimated $298M increase.
- David Shaw's biggest Q3 2014 reduction was Liberty Media Series A, cutting an estimated $321M.
- David Shaw fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $602M.
- David Shaw's ten largest holdings make up 12% of its $77.2B portfolio in Q3 2014.
- David Shaw opened 599 new positions and closed 674 in Q3 2014.
- David Shaw's portfolio value rose 5.1% quarter-over-quarter to $77.2B.
Based on D.E. Shaw & Co's 13F filing for Q3 2014, filed 14 Nov 2014.